Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
Aldona Kasprzak, Agnieszka Adamek
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3887-3887
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Colorectal liver metastasis: molecular mechanism and interventional therapy
Hui Zhou, Zhongtao Liu, Yongxiang Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 173
Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
Changyu Yao, Shilun Wu, Jian Kong, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 1, pp. 25-43
Open Access | Times Cited: 78
Systemic Therapy for Hepatocellular Carcinoma: Current Updates and Outlook
Yinjie Fan, Hang Xue, Hua‐chuan Zheng
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 233-263
Open Access | Times Cited: 46
Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities
Carmelo Laface, Palma Fedele, Felicia Maria Maselli, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4028-4028
Open Access | Times Cited: 46
Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma
Hui Li
Expert Review of Gastroenterology & Hepatology (2020) Vol. 15, Iss. 3, pp. 217-233
Closed Access | Times Cited: 60
The role of endoglin and its soluble form in pathogenesis of preeclampsia
Georgia Margioula‐Siarkou, Chrysoula Margioula‐Siarkou, Stamatios Petousis, et al.
Molecular and Cellular Biochemistry (2021) Vol. 477, Iss. 2, pp. 479-491
Closed Access | Times Cited: 54
Hepatocellular carcinoma-targeted nanoparticles for cancer therapy
Chien‐Hsun Wu, Chun-Hsin Lan, Kuan‐Lin Wu, et al.
International Journal of Oncology (2017)
Open Access | Times Cited: 41
Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma
Cedric Brackenier, Lisa Kinget, Sarah Cappuyns, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 348-348
Open Access | Times Cited: 12
Evaluation of Intra-Tumoral Vascularization in Hepatocellular Carcinomas
Qi Zhang, Jiajun Wu, Xueli Bai, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 32
Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and Treatment
Dongxu Zhao, Jian Cao, Lei Zhang, et al.
Biosensors (2022) Vol. 12, Iss. 5, pp. 342-342
Open Access | Times Cited: 17
To construct and validate a risk score model of angiogenesis-related genes to predict the prognosis of hepatocellular carcinoma
Duangui Gao, Lu Yuan, Tianpeng Jiang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Integrative Analysis the Role of ENG as a Metabolic and Macrophage-Related Gene in Hepatocellular Carcinoma
Songsong Fan, Yuhong Tang, Jun Cao, et al.
Biochemical Genetics (2025)
Closed Access
The prognostic role of Angiogenesis, Lymphangiogenesis and Vasculogenic mimicry in Hepatocellular Carcinomas treated with Transplantation
Gülen Gül, Tarkan Ünek, Anil Aysal Agalar, et al.
Medical Science and Discovery (2025) Vol. 12, Iss. 5, pp. 172-180
Open Access
Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma
Jung Woo Eun, Chul Won Seo, Geum Ok Baek, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3819-3819
Open Access | Times Cited: 24
Novel insights for lncRNA MAGI2-AS3 in solid tumors
Chen Xue, Ganglei Li, Juan Lü, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111429-111429
Open Access | Times Cited: 23
Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights
Bahare Shokoohian, Babak Negahdari, Hamidreza Aboulkheyr Es, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 18, pp. 8602-8614
Open Access | Times Cited: 21
The Cardiac Glycoside Deslanoside Exerts Anticancer Activity in Prostate Cancer Cells by Modulating Multiple Signaling Pathways
Mingcheng Liu, Qingqing Huang, Jun Arita, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5809-5809
Open Access | Times Cited: 21
Deciphering hepatoma cell resistance to tyrosine kinase inhibitors: insights from a Liver-on-a-Chip model unveiling tumor endothelial cell mechanisms
Madhu Shree Poddar, Yu‐De Chu, Chau‐Ting Yeh, et al.
Lab on a Chip (2024) Vol. 24, Iss. 15, pp. 3668-3678
Closed Access | Times Cited: 3
Angiogenesis of hepatocellular carcinoma: An immunohistochemistry study
Decebal Fodor, Ioan Jung, Sabin Gligore Turdean, et al.
World Journal of Hepatology (2019) Vol. 11, Iss. 3, pp. 294-304
Open Access | Times Cited: 25
The Role of Endoglin in Hepatocellular Carcinoma
Kuo‐Shyang Jeng, I‐Shyan Sheen, Shu-Sheng Lin, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3208-3208
Open Access | Times Cited: 18
Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma
Mahsa Pourhamzeh, Samieh Asadian, Hamed Mirzaei, et al.
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 1, pp. 23-37
Closed Access | Times Cited: 13
Prognostic Significance of CD105- and CD31-Assessed Microvessel Density in Paired Biopsies and Surgical Samples of Laryngeal Carcinoma
Gino Marioni, Leonardo Franz, Giancarlo Ottaviano, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2059-2059
Open Access | Times Cited: 20
Raptinal silver nanoparticles: new therapeutic advances in hepatocellular carcinoma mouse model
Heba Taha, Nourhan Elfar, Hesham Haffez, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2020) Vol. 394, Iss. 2, pp. 279-289
Closed Access | Times Cited: 20
Receptor Tyrosine Kinase: Still an Interesting Target to Inhibit the Proliferation of Vascular Smooth Muscle Cells
Yilin Xiong, Yan Wang, Tao Yang, et al.
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 5, pp. 497-518
Closed Access | Times Cited: 7
A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effects
Shenxia Xie, Wei Shi, Siliang Duan, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top